ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$8.27
+0.01 (+0.12%)
As of Aug 15, 2:21 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +75.8% upside
Low Target $12.76
Average Target $14.54
High Target $24.66
Current Price $8.27
Current
$8.27
Target
$14.54
$12.76 $14.54 avg $24.66
Scenario Analysis
Bear Case
$12.76
54.3%
Low target
Base Case
$14.54
+75.8%
Avg target
Bull Case
$24.66
+198.2%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$17.44
-52.6% from high
52-Week Low
$6.01
+37.6% from low
Target vs 52W High
$14.54
-16.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%